These findings align with previous studies on healthy individuals3 allogeneic HCT recipients12, 54 and gene therapy recipients,55 as well as DNMT3A‐mutant blood‐derived lymphoblastoid cell lines and bulk AML samples.56, 57. Here, DNMT3A is linked to acute myeloid leukemia.